Title : Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

Pub. Date : 2013 Nov

PMID : 24070321






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EXPERT OPINION: Azilsartan medoxomil has a potent and persistent ability to inhibit binding of angiotensin II to AT1 receptors, which may play a role in its superior blood pressure (BP) -lowering efficacy compared with other drugs, including ramipril, candesartan, valsartan or olmesartan, without an increase of side effects. olmesartan angiotensin II receptor type 1 Homo sapiens